MRC Institute of Genetics & Molecular Medicine
MRC Institute of Genetics & Molecular Medicine

HTPU microarray services

Providing insights into the genetic and molecular basis of disease.

HTPU microarray services
HTPU microarray services

The MRC Institute of Genetics and Molecular Medicine/Cancer Research UK Edinburgh Centre houses cutting edge protein, antibody and transcriptomic microarray facilities for the analysis of complex signalling pathways and secreted factors (e.g. chemokines/cytokines) across multiple pre-clinical and clinical sample types. Our facility brings together industry leading platforms, like the high throughput Quanterix-2470-microarrayer, Innopsys 710 infra-red microarray scanner, Zeptosens RPPA system, and NanoString.

The technologies we offer in this facility are

  • Reverse Phase Protein Arrays
  • Forward Phase Antibody Microarrays
  • NanoString

Each microarray platform enables rapid and robust quantification of biomarkers at transcriptomic and post-translational pathway levels across multiple sample sets. Study size can be scaled to the needs of the experiment.

People

Professor Neil Carragher Academic Lead
Alison Munro Facility Manager and NanoString
Kenneth Macleod RPPA and FPA Technical Manager

Our facilities are available to all within the University of Edinburgh, and also to external groups through funded collaboration or fee-for-service contract.

NanoString

NanoString
Life science tools for translational research and molecular diagnostics

Reverse Phase Protein Arrays

Reverse Phase Protein Arrays
Rapid and robust quantification of biomarkers at the post-translational pathway level

Forward Phase Antibody Microarrays

Forward Phase Antibody Microarrays
Rapid detection of protein analytes including cytokine and chemokines across multiple samples